News
News from Holden
Filter by:
NCI-designated cancer centers call for urgent action to get HPV vaccination back on track
Cancers caused by human papillomavirus (HPV) are a significant public health problem in the United States. But these cancers are preventable with HPV vaccination.
Hydrogen peroxide producing drug boosts cancer-killing effect of radiotherapy
Drug simultaneously protects healthy tissue from harmful radiation side-effects.
Holden Comprehensive Cancer Center receives fourth renewal from the National Cancer Institute
University of Iowa Holden Comprehensive Cancer Center has received its fourth renewal as a comprehensive cancer center from the National Cancer Institute (NCI), part of the National Institutes of Health.
Musculoskeletal Tumor Registry collects QoL data after surgery in sarcoma
Benjamin J. Miller, MD, MS, discusses the creation of the Musculoskeletal Tumor Registry and how it is poised to make progress in the orthopedic oncology field with OncLive.
Work led by team at University of Iowa Holden Comprehensive Cancer Center enables greater access to targeted diagnosis and treatment of rare cancer
People with a rare cancer will have greater access to a drug enabling targeted diagnosis and treatment, thanks to work led by a team of researchers at University of Iowa Health Care’s PET Imaging Center.
Holden oncologist Muhammad Furqan, MD, receives NCI award for dedication to lung cancer clinical research
Furqan is one of eight recipients nationwide of the Cancer Clinical Investigator Team Leadership Award for outstanding work leading clinical trials.
Better incentives, infrastructure key to unlocking collaboration
True collaboration should be embedded in the practice of medicine. It should be baked in, a given, something we don’t need to write columns on.
When he ran out of options, Kent found the kidney cancer treatment he needed in a clinical trial
Tumors that had spread to Kent’s lungs were eliminated by a new immunotherapy offered in a clinical trial at Holden Comprehensive Cancer Center.